Research programme: interleukin 4 receptor alpha antagonists - Ventyx Biosciences
Alternative Names: IL-4Rα antagonists - Ventyx BiosciencesLatest Information Update: 19 Feb 2023
At a glance
- Originator Ventyx Biosciences
- Class Anti-inflammatories; Antiasthmatics; Skin disorder therapies; Small molecules
- Mechanism of Action Interleukin 4 receptor alpha subunit antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Asthma; Atopic dermatitis; Autoimmune disorders; Eosinophilic oesophagitis